#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	12854	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2094	605.9	0	.	n	.	0	C451T	SNP	451	451	C	668	668	T	759	T,C	344,395	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	12854	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2094	605.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1401	1401	C	719	C,T	695,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	12854	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2094	605.9	0	HET	.	.	.	C207T	.	207	207	C	424	424	C	711	C,T	578,103	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23788	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3545	665.2	0	.	n	.	0	T695C	SNP	695	695	T	1030	1030	C	769	C,T	696,53	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23788	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3545	665.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2306	2306	C	750	C,T,A	721,2,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23788	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3545	665.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2380	2380	A	725	A	701	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23788	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3545	665.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2932	2932	C	717	C,T	691,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23788	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3545	665.2	0	HET	.	.	.	A1638G	.	1638	1638	A	1973	1973	A	710	A,G	399,287	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1578	folP	855	855	100.0	folP.l15.c17.ctg.1	1529	102.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1081	1083	AGC	156;157;161	A;G;C	149;150;150	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	4368	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3204	134.5	1	SNP	p	S91F	1	.	.	271	273	TTC	525	527	TTC	159;159;160	T;T;C	157;156;154	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	4368	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3204	134.5	1	SNP	p	G95N	0	.	.	283	285	GGC	537	539	GGC	160;157;155	G;G;C,A	156;153;150,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	4368	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3204	134.5	1	SNP	p	D95G	1	.	.	283	285	GGC	537	539	GGC	160;157;155	G;G;C,A	156;153;150,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1362	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1341	100.8	1	SNP	p	G45D	0	.	.	133	135	GGC	382	384	GGC	165;164;164	G;G;C	158;158;155	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	726	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1057	67.1	0	.	n	.	0	A197.	DEL	197	197	A	656	656	A	179	A	174	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4486	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2936	151.6	1	SNP	p	D86N	0	.	.	256	258	GAC	567	569	GAC	189;189;189	G;A;C	183;178;182	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4486	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2936	151.6	1	SNP	p	R87W	0	.	.	259	261	CGT	570	572	CGT	191;190;188	C;G;T	188;185;180	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4486	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2936	151.6	1	SNP	p	R87I	0	.	.	259	261	CGT	570	572	CGT	191;190;188	C;G;T	188;185;180	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4486	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2936	151.6	1	SNP	p	S87R	1	.	.	259	261	CGT	570	572	CGT	191;190;188	C;G;T	188;185;180	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4486	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2936	151.6	1	SNP	p	S88P	0	.	.	262	264	TCC	573	575	TCC	189;193;194	T;C;C	183;187;189	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3164	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2553	122.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1528	1530	GGC	161;160;158	G;G;C,A	157;155;152,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	155	3350	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2202	145.8	1	SNP	p	A311V	0	.	.	931	933	GCC	1200	1202	GCC	179;180;180	G;C;C,A	170;173;167,5	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	155	3350	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2202	145.8	1	SNP	p	I312M	1	.	.	934	936	ATG	1203	1205	ATG	180;179;179	A;T;G,C	175;173;168,5	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	155	3350	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2202	145.8	1	SNP	p	V316T	1	.	.	946	948	ACC	1215	1217	ACC	183;182;184	A,G;C,T;C,G	172,3;175,3;178,3	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	155	3350	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2202	145.8	1	SNP	p	T316P	0	.	.	946	948	ACC	1215	1217	ACC	183;182;184	A,G;C,T;C,G	172,3;175,3;178,3	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	155	3350	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2202	145.8	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1716	1718	ACC	157;160;162	A;C;C	142;152;155	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	155	3350	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2202	145.8	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1770	1772	GCG	141;141;140	G,A;C;G	137,1;133;137	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	155	3350	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2202	145.8	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1770	1772	GCG	141;141;140	G,A;C;G	137,1;133;137	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	155	3350	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2202	145.8	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1893	1895	GGT	136;135;133	G;G;T,C	130;129;116,11	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	155	3350	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2202	145.8	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1902	1904	AGC	124;125;124	A,G;G;C	103,13;118;117	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	155	3350	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2202	145.8	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1920	1922	CCG	97;102;101	C,T,G;C,G;G	69,8,5;84,2;89	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	155	3350	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2202	145.8	0	HET	.	.	.	A294G	.	294	294	A	563	563	A	156	A,G	135,17	.	.
penA.34.001	penA.34.001	1	1	155	3350	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2202	145.8	0	HET	.	.	.	C479T	.	479	479	C	748	748	C	196	C,T	169,21	.	.
penA.34.001	penA.34.001	1	1	155	3350	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2202	145.8	0	HET	.	.	.	T417C	.	417	417	T	686	686	T	172	T,C	146,19	.	.
penA.34.001	penA.34.001	1	1	155	3350	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2202	145.8	0	HET	.	.	.	C411T	.	411	411	C	680	680	C	178	C,T	152,19	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4882	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3033	159.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1554	1556	CCG	176;176;177	C;C;G	161;170;168	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1982	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1731	113.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	515	515	C	139	C,G	130,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	155	2340	porB1b	1038	1038	100.0	porB1b.l15.c30.ctg.1	1328	170.7	1	SNP	p	G120K	1	.	.	358	360	AAG	531	533	AAG	193;193;193	A,C;A;G,A	183,1;183;176,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	155	2340	porB1b	1038	1038	100.0	porB1b.l15.c30.ctg.1	1328	170.7	1	SNP	p	N121D	0	.	.	361	363	AAC	534	536	AAC	196;195;195	A,G;A;C	172,16;184;181	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	155	2340	porB1b	1038	1038	100.0	porB1b.l15.c30.ctg.1	1328	170.7	1	SNP	p	A121N	1	.	.	361	363	AAC	534	536	AAC	196;195;195	A,G;A;C	172,16;184;181	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	155	2340	porB1b	1038	1038	100.0	porB1b.l15.c30.ctg.1	1328	170.7	0	HET	.	.	.	A223G,C	.	223	223	A	396	396	A	185	A,G,C	155,20,2	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	155	2340	porB1b	1038	1038	100.0	porB1b.l15.c30.ctg.1	1328	170.7	0	HET	.	.	.	A880G	.	880	880	A	1053	1053	A	219	A,G	194,23	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	155	2340	porB1b	1038	1038	100.0	porB1b.l15.c30.ctg.1	1328	170.7	0	HET	.	.	.	A865T	.	865	865	A	1038	1038	A	216	A,T	186,22	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8726	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4803	179.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	944	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	919	101.4	1	SNP	p	V57M	1	.	.	169	171	ATG	475	477	ATG	188;190;185	A;T;G	185;184;180	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
